Last update: July 2, 2015
Not risky for breastfeeding or infant.
At latest update, relevant published data on excretion into breast milk were not found.
Because of high serum protein-binding capacity, excretion into breast milk in significant amount is seemingly unlikely.
Its low oral bioavailability causes a poor absorption into infant's serum as from breast milk, except in prematures and in the early neonatal period in which intestinal absorption may be increased.
Bromhexine is metabolized into Ambroxol. Known adverse reactions are rare and mild. Secretion of Prolactin and other hormones have not been affected by taking this medication.
Effectiveness of this drug has not been established.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM